Purple Biotech : Immediate report on other matter -October 30, 2023 at 05:04 pm EDT

As filed with the Securities and Exchange Commission on October 30, 2023


Registration No. 333-


UNITED STATES


...

Related Keywords

United States ,Israel ,District Of Columbia ,Washington ,Lebanon ,Tel Aviv Yafo ,Tel Aviv ,Gaza Strip ,Rehovot ,Hamerkaz ,New York ,Israeli ,State Of Israel ,American ,Ricka Werner ,Rockefeller Plaza ,Jayun Koo ,Sharon Rosen ,Lior Fhima ,Hc Wainwright Co ,Bristol Myers Squibb ,Tel Aviv Stock Exchange ,Nasdaq ,Drug Administration ,Tyrnovo Ltd ,Foreign Investment Company ,Exchange Commission ,Immunorizon Ltd ,Purple Biotech Ltd ,Famewave Ltd ,Exchange Commission On ,Primary Standard Industrial ,Code Number ,Chief Financial Officer ,Menachem Begin ,Securities Act ,Financial Accounting Standards Board ,Accounting Standards Codification ,Registration Statement ,Depositary Shares ,American Depositary Share ,October Warrants ,Placement Agent Warrants ,Securities Purchase Agreement ,Nasdaq Capital Market ,Ordinary Shares ,Passive Foreign Investment Company ,Qualified Electing Fund ,Annual Report ,Civil Liabilities ,Purple Biotech ,Purple Biotech Gmbh ,New Israeli Shekels ,Investigational New Drug Application ,New Drug Application ,Biologics License Application ,Insulin Receptor Substrate ,Signal Transducer ,Tumor Associated Antigen ,Registered Direct Offering ,Concurrent Private Placement ,October Warrant ,October Offering ,Registration Rights Agreements ,Dilution Share ,Science Park ,Deposit Agreement ,Statement Regarding Forward Looking Statements ,Current Condition ,Markets ,